Effects of the menstrual cycle on medical disorders

Archives of Internal Medicine

Volumn 158, Issue 13, 1998, Pages 1405-1412

  Case, Allison M ^a   Reid, Robert L ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CONJUGATED ESTROGEN; CORTICOSTEROID; DANAZOL; GONADORELIN AGONIST; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; SUMATRIPTAN SUCCINATE; TAMOXIFEN CITRATE;

ABDOMINAL HYSTERECTOMY; ASTHMA; DIABETES MELLITUS; DOSE RESPONSE; DRUG MIXTURE; EPILEPSY; ESTROGEN THERAPY; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; INTRAMUSCULAR DRUG ADMINISTRATION; IRRITABLE COLON; MENSTRUAL CYCLE; MIGRAINE; ORAL DRUG ADMINISTRATION; OVULATION INHIBITION; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SALPINGOOOPHORECTOMY;

ARTHRITIS, RHEUMATOID; ASTHMA; CHRONIC DISEASE; COLONIC DISEASES, FUNCTIONAL; DIABETES MELLITUS; EPILEPSY; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; MENSTRUAL CYCLE; MIGRAINE DISORDERS; OVULATION;

EID: 0032527655     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.13.1405     Document Type: Review

References (156)

1. Reid RL, van Vugt DA. Neuroendocrine events that regulate the menstrual cycle. Contemp Obstet Gynecol. 1987;30:147-155.
2. Speroff L, Glass RH, Kase NG. Clinical Gynecologic Endocrinology and Infertility. 5th ed. Baltimore, Md: Williams & Wilkins; 1994.
3. Reid RL. Use of GnRH agonists for menstrual cycle-related disorders. J Soc Obstet Gynecol Can. 1992;14:59-65.
4. Mortola JF, Girton L, Fischer U. Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen/progestin. J Clin Endocrinol Metab. 1991;72:252A-F.
5. Linet MS, Stewart WF. Migraine headache: epidemiologic perspectives. Epidemiol Rev. 1984;6:107.
6. Bille B. Migraine in school children. Acta Pediatr. 1962;51(suppl 136):1-151.
7. Manzoni GC, Granellla F, Malferrari G, Cavalieri R, Bizzi P, Ferrari AM. An epidemiological study of headache in children aged between 6 and 13. In: Lanzi G, Balottin U, Cernibori A, eds. Headache in Children and Adolescents. Amsterdam, the Netherlands: Elsevier Science Publishers; 1989: 185-188.
8. Nattero L. Menstrual headache. Adv Neurol. 1982;33:215-226.
9. Granella F, Sances G, Zanferrari C, Costa A, Martignoni E, Manzoni GC. Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women. Headache. 1993; 33:385-389.
10. Epstein MT, Hockaday JM, Hockaday TDR. Migraine and reproductive hormones throughout the menstrual cycle. Lancet. 1975;1:543-548.
11. Digre K, Damasio H. Menstrual migraine: differential diagnosis, evaluation and treatment. Clin Obstet Gynaecol. 1987;30:417-430.
12. Edelson RN. Menstrual migraine and other hormonal aspects of migraine. Headache. 1985; 25:376-379.
13. Donaldson JO. Neurology of Pregnancy. Philadelphia, Pa: WB Saunders Co; 1978.
14. Stein GS. Headaches in the first postpartum week and their relationship to migraine. Headache. 1981;21:201-205.
15. Silberstein SD. The role of sex hormones in headache. Neurology. 1992;42(suppl 2):37-42.
16. Whitty CWM, Hockaday JM, Whitty MM. The effect of oral contraceptive on migraine. Lancet. 1966;1:856-859.
17. Kaiser HJ, Meienberg O. Deterioration or onset of migraine under oestrogen replacement therapy in the menopause. J Neurol. 1993;240: 195-196.
18. Dalessio DJ. Wolff's Headache and Other Head Pain. New York, NY: Oxford University Press Inc; 1980.
19. Damasio H, Beck D. Migraine, thrombocytopenia and serotonin metabolism. Lancet. 1978;1: 240-242.
20. Lance JW. Headache. Ann Neurol. 1988;10: 1-10.
21. Crook M. Migraine: a biochemical headache? Biomed Soc Trans. 1981;9:351-357.
22. Petraglia F, Martignoni E, Sola D, et al. Evaluation of central opioid tonus in menstrual migraine. Cephalalgia. 1983;1 (suppl):98-100.
23. Nattero G, Allais G, DeLorenzo C, et al. Relevance of prostaglandins in true menstrual migraine. Headache. 1989;29:232-238.
24. Salvatore CA. Arterioles of the endometrium in the etiopathogenesis of dysfunctional hemorrhage. J Int Coll Surg. 1958;29:599.
25. Salvatore CA. Arteriole supply in normal and hyperplastic endometrium. Am J Obstet Gynecol. 1968;102:493.
26. Grant ECG. Relation of arterioles in the endometrium to headache from oral contraceptives. Lancet 1965;1:1143-1144.
27. Grant ECG. Relation between headache from oral contraceptives and development of endometrial arterioles. BMJ. 1968;3:402-405.
28. Sommerville BW. The role of estrogen withdrawal in the etiology of menstrual migraine. Neurology. 1972;22:355-365.
29. Silberstein SD, Merriam GR. Estrogens, progestins, and headache. Neurology. 1991;41: 786-793.
30. DeLigniéres B, Vincens M, Mauvais-Jarvis P, Mas JL, Touboul PJ, Bousser MG. Prevention of menstrual migraine by percutaneous oestradiol. BMJ. 1986;293:1540.
31. Magos AL, Zikha KJ, Studd JWW. Treatment of menstrual migraine by oestradiol implants. J Neurol Neurosurg Psychiatry. 1983;46:1044-1046.
32. Raskin NH. Headache. 2nd ed. New York, NY: Churchill Livingstone Inc; 1988.
33. Sommerville BW. Estrogen-withdrawal migraine, I: duration of exposure required and attempted prophylaxis by premenstrual estrogen administration. Neurology. 1975;25:239-244.
34. Sommerville BW. Estrogen-withdrawal migraine, II: attempted prophylaxis by continuous estradiol administration. Neurology. 1975;25: 245-250.
35. Sarrel PM. Blood flow and ovarian secretions. In: Naftolin F, DeCherney A, Gutmann JN, Sarrel PM, eds. Ovarian Secretions and Cardiovascular and Neurological Function. Vol 80. New York, NY: Raven Press; 1990:81-89.
36. Powles TJ. Prevention of migrainous headaches by tamoxifen. Lancet. 1986;2:1344.
37. Solbach MP, Waymer RS. Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan. Obstet Gynecol. 1993; 82:769-772.
38. Calton GJ, Burnett JW. Danazol and migraine. N Engl J Med. 1984;310:721-722.
39. Sarno AP, Miller EJ, Lundblad EG. Premenstrual syndrome: beneficial effects of periodic, low-dose danazol. Obstet Gynecol. 1987;70:33-36.
40. Murray SC, Muse KN. Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and "add-back" therapy. Fertil Steril. 1997;67:390-393.
41. Boggess KA, Williamson HO, Homm RJ. Influence of the menstrual cycle on systemic disease. Obstet Gynecol Clin North Am, 1990;17: 321-342.
42. Duncan S, Read CL, Brodie MJ. How common is catamenial epilepsy? Epilepsia. 1993;34: 827-831.
43. Newmark ME, Penry JK. Catamenial epilepsy: a review. Epilepsia. 1980;21:281-300.
44. Lennox WG, Lennox MA. Epilepsy and Related Disorders. Vol 2. Boston, Mass: Little Brown & Co Inc; 1960:645-650.
45. Holmes GL. Effects of menstruation and pregnancy on epilepsy. Semin Neurol. 1988;8: 234-239.
46. Bäckström T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand. 1976; 54:321-347.
47. Zimmerman AW. Hormones and epilepsy. Neurol Clin. 1986;4:853-861.
48. Bäckström T, Zetterlund B, Blom S, Romano M. Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy. Acta Neurol Scand. 1984; 69:240-248.
49. Mattson RH, Kamer JA, Cramer JA, Caldwell BV. Seizure frequency and the menstrual cycle: a clinical study. Epilepsia. 1981;22:242.
50. Magos A, Studd JW. Effects of the menstrual cycle on medical disorders. Br J Hosp Med. 1985;33:70-76.
51. Rosciszewska D, Buntner B, Guz I, Zawisza L. Ovarian hormones, anticonvulsant drugs, and seizures during the menstrual cycle in women with epilepsy. J Neurol Neurosurg Psychiatry. 1986; 49:47-51.
52. Herzog AG, Seibel MM, Schomer DL, Vaitukaitis JL, Geschwind N. Reproductive endocrine disorders in women with partial seizures of temporal lobe origin. Arch Neurol. 1986;43:341-346.
53. Bilo L, Meo R, Nappi C, et al. Reproductive endocrine disorders in women with primary generalized epilepsy. Epilepsia. 1988;29:612-619.
54. Cramer JA, Jones EE. Reproductive function in epilepsy. Epilepsia. 1991;32(suppl 6):S19-S26.
55. Isojarvi JL, Laatikainen TJ, Pakarinen AJ, Juntunen KTS, Myllyla VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med. 1993;329:1383-1388.
56. Cummings LN, Giuduce L, Morrell M. Ovulatory function in epilepsy. Epilepsia. 1995;36: 355-359.
57. Shavit G, Lerman P, Korczyn AD, et al. Phenytoin pharmacokinetics in catamenial epilepsy. Neurology. 1984;34:959-961.
58. Kumar N, Behari M, Aruja GK, Jailhani BL. Phenytoin levels in catamenial epilepsy. Epilepsia. 1988;29:155-158.
59. Dana-Haeri J, Richens A. Effect of norethisterone on seizures associated with menstruation. Epilepsia. 1983;24:377-381.
60. Mattson RH, Cramer JA, Siconolfi BC, Caldwell BV. Treatment of seizures with medroxyprogesterone acetate. Neurology. 1984;34:1255-1258.
61. Hall SM. Treatment of menstrual epilepsy with a progesterone-only contraceptive. Epilepsia. 1977;18:235-236.
62. Herzog AG. Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders. Neurology. 1986;36: 1607-1610.
63. Dawson B, Horobin G, Illsley R, Mitchell R. A survey of childhood asthma in Aberdeen. Lancet. 1969;1:827-830.
64. Schachter J, Higgins MW. Median age at onset of asthma and allergic rhinitis in Tecumseh Michigan. J Allergy Clin Immunol. 1976;57:342.
65. Hanley SP. Asthma variation with menstruation. Br J Dis Chest. 1981;75:306-308.
66. Gibbs CJ, Counts II, Lock R, et al. Premenstrual exacerbations of asthma. Thorax. 1984;39: 833-836.
67. Eliasson O, Scherzer HH. Recurrent respiratory failure in premenstrual asthma. Conn Med. 1984; 48:777.
68. Eliasson O, Scherzer H, DeGraff AC. Morbidity in asthma in relation to the menstrual cycle. J Allergy Clin Immunol. 1986;77:87-94.
69. Schoene RB, Robertson HT, Pierson DJ, Peterson AP. Respiratory drives and exercise in menstrual cycles of athletic and non-athletic women. J Appl Physiol. 1981;50:1300-1305.
70. Moore LG, McCullough RE, Weil JV. Increased HVR in pregnancy: relationship to hormonal and metabolic changes. J Appl Physiol. 1987;62: 158-163.
71. Pauli BD, Reid RL, Munt PW, Wigle RD, Forkert L. Influence of the menstrual cycle on airway function in asthmatic and normal subjects. Am Rev Respir Dis. 1989; 140:358-362.
72. Eliasson O, Densmore MJ, Scherzer HH, DeGraff AC, Jr. The effect of sodium meclofenamate in premenstrual asthma: a controlled clinical trial. J Allergy Clin Immunol. 1987;79: 909-918.
73. Juniper EF, Kline PA, Robbers RS, et al. Airway responsiveness to methacholine during the natural menstrual cycle and the effect of oral contraceptives. Am Rev Respir Dis. 1987;135: 1039-1042.
74. Ozkaragoz K, Cakin F. The effect of menstruation on immediate skin reactions in patients with respiratory allergy. J Asthma Res. 1970;7:171.
75. Beynon HLC, Garbett ND, Barnes PJ. Severe premenstrual exacerbations of asthma: effect of intramuscular progesterone. Lancet 1988;2: 370-372.
76. Neeley NT, Persellin RH. Activity of rheumatoid arthritis during pregnancy. Tex Med. 1977;73: 59-63.
77. Oka M, Vaino U. Effect of pregnancy on the prognosis and serology of rheumatoid arthritis. Acta Rheum Scand. 1966;12:47-52.
78. Ostensen M, Aune B, Husby G. Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand J Rheumatol. 1983; 12:69-72.
79. Latman NS. Relation of menstrual cycle phase to symptoms of rheumatoid arthritis. Am J Med. 1983;74:957-960.
80. Rudge SR, Kowanko IC, Drury PL. Menstrual cyclicity of finger joint size and grip strength in patients with rheumatoid arthritis. Ann Rheum Dis. 1983;42:425-430.
81. McDonagh JE, Singh MM, Griffiths ID. Menstrual arthritis. Ann Rheum Dis. 1993;52:65-66.
82. Halka JF, Omran KF. The uterine cervix as a potential local antibody secretor. Am J Obstet Gynecol. 1969;104:440-442.
83. Wira CR, Sandoe CP. Sex steroid hormone regulation of IgA and IgG in rat uterine secretion. Nature. 1977;268:534-535.
84. Mathur S, Rajesh SM, Goust JM, Oliver WH, Fudenberg HH. Cyclic variations in the human menstrual cycle: correlations with progesterone and estradiol. Clin Immunol Immunopathol. 1979;13:246-253.
85. Persellin RH. The effect of pregnancy on rheumatoid arthritis. Bull Rheum Dis. 1977;27: 922-927.
86. Bodel P, Dillard GM, Kaplan SS, Malawista SE. Anti-inflammatory effects of estradiol on human blood leukocytes. J Lab Clin Med. 1972; 80:373-384.
87. Mueller MN, Kappas A. Sex hormones in experimental and human arthritis. Proc Inst Med Chicago. 1963;24:303-304.
88. Linos A, Wothington JW, O'Fallon WM, Kurland LT. Rheumatoid arthritis and oral contraceptives [letter]. Lancet. 1978;1:871.
89. Alarcon GS. Epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am. 1995;21: 590-604.
90. Wingrave SJ, Kay CR. Reduction in incidence of rheumatoid arthritis associated with oral contraceptives. Lancet. 1978;1:569-571.
91. Spector TD, Hochberg MC. The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytic epidemiological studies using meta-analysis. J Clin Epidemiol. 1990;43:1221-1230.
92. Da Suva JAP, Hall GM. The effects of gender and sex hormones on the outcome in rheumatoid arthritis. Clin Rheumatol. 1992;6:196-219.
93. Hernandez-Avila M, Liang MH, Willett WC, et al. Exogenous sex hormones and the risk of rheumatoid arthritis. Arthritis Rheum. 1990;33: 947-953.
94. Sandler RS. Epidemiology of irritable bowel syndrome in the US. Gastroenterology. 1990; 99:409-412.
95. Schuster M. Diagnostic evaluation of the IBS. Gastroenterol Clin North Am. 1991;20: 269-278.
96. Mitchell CM, Drossman DA. Survey of the AGA membership relating to functional gastrointestinal disorders. Gastroenterology. 1987;92: 1283-1284.
97. Whitehead WE, Cheskin LJ, Heller BR, et al. Evidence for exacerbation of irritable bowel syndrome during menses. Gastroenterology. 1990; 98:1485-1489.
98. Mathias JR, Clench MH, Reeves-Darby VG, et al. Effect of leuprolide acetate in patients with moderate to severe functional bowel disease: double-blind, placebo controlled study. Dig Dis Sci. 1994; 39:1155-1162.
99. Fisher RS, Robert GS, Graowski CJ, et al. Inhibition of lower esophageal sphincter circular muscle by female sex hormones. Am J Physiol. 1978;23:243-287.
100. Datz FL, Christian PE, Moore JC. Gender-related differences in gastric emptying. J Nucl Med. 1987;28:1204-1207.
101. Wald A, Thiel DH, Hoechstetter L, et al. Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology. 1981;80:1497-1500.
102. Davies GJ, Crowder M, Reid B, et al. Bowel function measurements of individuals with different eating patterns. Gut. 1986;27:154-169.
103. Wyman JB, Heaton KW, Manning AP, et al. Variability of colonic function in healthy subjects. Gut. 1978;19:146-150.
104. Hinds JP, Stoney B, Wald A. Does gender or the menstrual cycle affect colonic transit? Am J Gastroenterol. 1989;84:123-126.
105. Turnbull GK, Thompson DG, Day S, Martin J, Walker E, Lennard-Jones JE. Relationships between symptoms, menstrual cycle and orocaecal transit in normal and constipated women. Gut. 1989;30:30-34.
106. Kamm MA, Farthing MJG, Lennard-Jones JE. Bowel function and transit rate during the menstrual cycle. Gut. 1989;30:605-608.
107. Heitkemper M, Jarrett M. Pattern of gastrointestinal and somatic symptoms across the menstrual cycle. Gastroenterology. 1992;102: 505-513.
108. Rees WDW, Rhodes JWT. Altered bowel habit and menstruation [letter]. Lancet. 1976;2:475.
109. Bennett A. Effects of prostaglandins on the gastrointestinal tract. In: Karim SM, ed. The Prostaglandins: Progress in Research. New York, NY: Wiley Interscience; 1972:205-221.
110. Wood JD. Efficacy of leuprolide in treatment of the irritable bowel syndrome. Dig Dis Sci. 1994; 39:1153-1154.
111. Mathias JR, Clench MH, Roberts PH, Reeves-Darby VG. Effects of leuprolide acetate in patients with functional bowel disease: long-term follow-up after double-blind, placebo-controlled study. Dig Dis Sci, 1994;39:1163-1170.
112. Widom B, Diamond MP, Simonson DC. Alterations in glucose metabolism during menstrual cycle in women with IDDM. Diabetes Care. 1992; 15:213-220.
113. Letterie GS, Fredlund PN. Catamenial insulin reactions treated with a long-acting gonadotropin-releasing hormone agonist. Arch Intern Med. 1994;154:1868-1870.
114. Walsh CH, Malins JM. Menstruation and control of diabetes. BMJ. 1977;2:177-179.
115. Sacerdote A, Bleiker SJ. Oral contraceptives abolish luteal phase exacerbation of hyperglycemia in type I diabetes. Diabetes Care. 1982;5:651-652.
116. Hubble D. Insulin resistance. BMJ. 1954;2: 1022-1024.
117. De Pirro R, Fusco A, Bertoli A, Greco AV, Lauro R. Insulin receptors during the menstrual cycle in normal women. J Clin Endocrinol Metab. 1978; 47:1387-1389.
118. Bertoli A, De Pirro R, Fusco A, Greco AV, Magnatta R, Lauro R. Differences in insulin receptors between men and menstruating women and influence of sex hormones on insulin binding during the menstrual cycle. J Clin Endocrinol Metab. 1980;50:246-250.
119. Moore P, Kolterman O, Weyant J, Olefsky JM. Insulin binding in human pregnancy: comparisons to the postpartum, luteal and follicular states. J Clin Endocrinol Metab. 1981;52:937-941.
120. Pedersen O, Hjollund E, Lindsskov HO. Insulin binding and action on fat cells from young healthy females and males. Am J Physiol. 1982;243: E158-E167.
121. Roy SK, Ghosh BP, Bhattacharjee SK. Changes in oral glucose tolerance during normal menstrual cycle. J Indian Med Assoc. 1971;57: 201-204.
122. Jarrett RJ, Graver HJ. Changes in oral glucose tolerance during the menstrual cycle. BMJ. 1968; 2:528-529.
123. Diamond MP, Wentz AC, Cherrington AD. Alterations in carbohydrate metabolism as they apply to reproductive endocrinology. Fertil Steril. 1988;50:387-397.
124. Kalkhoff RK. Effects of oral contraceptive agents on carbohydrate metabolism. J Steroid Biochem. 1975;6:949-956.
125. van der Vange N, Kloosterboer HJ, Haspels AA. Effect of seven low-dose combined oral contraceptive preparations on carbohydrate metabolism. Am J Obstet Gynecol. 1987;156:918-922.
126. Kalkhoff RK. Metabolic effects of progesterone. Am J Obstet Gynecol. 1982;142:735-738.
127. Godsland IF, Crook D, Simpson R, et al. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl Med. 1990;323:1375-1381.
128. Spellacy WN. Carbohydrate metabolism during treatment with estrogen, progesterone, and low-dose oral contraceptives. Am J Obstet Gynecol. 1982;142:732-734.
129. Smith S, Sauder C. Food cravings, depression and premenstrual problems. Psychosom Med. 1969;36:281-287.
130. Both-Orthman B, Rubinow D, Hoban C, et al. Menstrual cycle phase-related changes in appetite in patients with premenstrual syndrome and in control subjects. Am J Psychiatry. 1988;145: 628-631.
131. Dalvit-McPhillips S. The effect of the human menstrual cycle on nutrient intake. Physiol Behav. 1983;31:209.
132. Tomelleri R, Gruewald K. Menstrual cycle and food cravings in young college women. J Am Diet Assoc. 1987;87:311-315.
133. Maurer ER, Schaal FA, Mendez FL. Chronic recurring spontaneous pneumothorax due to endometriosis of the diaphragm. JAMA. 1958;168: 2013-2024.
134. Foster DC, Stern JL, Buscema J, et al. Pleural and parenchymal pulmonary endometriosis. Obstet Gynaecol. 1981;58:552-556.
135. Markham SM, Carpenter SE, Rock JA. Extrapelvic endometriosis. Obstet Gynecol Clin North Am. 1989;16:193-207.
136. Karpel JP, Appell D, Merav A. Pulmonary endometriosis. Lung. 1985;163:151-159.
137. Shahar J, Angelilla VA. Catamenial pneumomediastinum. Chest. 1986;90:776-777.
138. Muller NL, Nelems B. Postcoital catamenial pneumothorax. Am Rev Respir Dis. 1986;134: 803-804.
139. Lillington GA, Mitchell SP, Wood GA. Catamenial pneumothorax. JAMA. 1972;219:1328-1332.
140. Slabbynck H, Laureys M, Impens N, DeVroey P, Schandevyl W. Recurring catamenial pneumothorax treated with a GnRH analogue. Chest. 1991;100:851.
141. Short AR. The causation of appendicitis. Br J Surg. 1920;8:171-188.
142. Arnbjonsson E. Acute appendicitis risk in various phases of the menstrual cycle. Acta Chir Scand. 1983;149:603.
143. Arnbjornsson E. The influence of oral contraceptives on the frequency of acute appendicitis in different phases of the menstrual cycle. Surg Gynecol Obstet. 1984;158:464-466.
144. Paterson GD, Miller SJH. Hormonal influence in simple glaucoma. Br J Ophthalmol. 1963;47:129-137.
145. Dalton K. Influence of menstruation on glaucoma. Br J Ophthalmol. 1967;51:692-695.
146. Smith R, Studd JW. A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle. J R Soc Med. 1992;85:612-613.
147. Caughey SC, Margesson LJ, Reid RL. Erythema multiforme with ulcerative stomatitis at menstruation. Can J Obstet Gynecol. 1990;112-113.
148. Howard RE. Premenstrual urticaria and dermatographism [letter]. JAMA. 1981;245:1068.
149. Rosano GMC, Leonardo F, Sarrel P, Beale CM, DeLuca F, Collins P. Cyclical variation in paroxysmal supraventricular tachycardia in women. Lancet. 1996;347:786-788.
150. Anderson KE, Spitz IM, Sassa S, Bardin W, Kappas A. Prevention of cyclical attacks of acute intermittent porphyria with a long-acting agonist of luteinizing hormone-releasing hormone. N Engl J Med. 1984;311:643-645.
151. Meggs WJ, Pescovitz OH, Metcalfe D, et al. Progesterone sensitivity as a cause of recurrent anaphylaxis. N Engl J Med. 1984;311:1236-1238.
152. Slater JE, Raphael G, Cutler GB, et al. Recurrent anaphylaxis in menstruating women: treatment with a luteinizing hormone-releasing hormone agonist - a preliminary report. Obstet Gynecol. 1987;70:542-546.
153. Vijayan N, Vijayan VK, Dreyfuss PM. Acetylcholinesterase activity and menstrual remissions in myasthenia gravis. J Neurol Neurosurg Psychiatry. 1977;40:1060-1065.
154. Keynes G. Obstetrics and gynaecology in relation to thyrotoxicosis and myasthenia gravis. J Obstet Gynaecol. 1952;59:173-182.
155. Badue RA. Timing of surgery during the cycle and breast cancer survival. Lancet. 1991;337: 1261-1264.
156. Wobbes T, Thomas CM, Segers MF, Peer PG, Bruggink ED, Beex LV. The phase of the menstrual cycle has no influence on the disease-free survival of patients with mammary carcinoma. Br J Cancer. 1994;69:599-600.